Howard Hospital rises in the ranks

Frank Howard Memorial Hospital’s makeover is complete, with a flood of new equipment capable of offering patients better, faster care. Improvements include new hospital beds, portable X-ray machines, 3D mammography and more.

Cancer Supportive Care Products Market Worth US $31.7 Billion by 2021

The global cancer supportive care products market is projected to expand at a CAGR of 4.3% during the forecast period . Cancer supportive care products are mainly used in the treatment of adverse effects associated with cancer therapy as well as for treatment of symptoms and signs of cancer, such as chemotherapy-induced nausea and vomiting, chemotherapy induced neutropenia and anemia, bone metastasis, hair loss, etc.

Prostate cancer laser therapy ‘huge leap forward’

A drug activated by laser light which successfully destroys early prostate cancer while avoiding surgery side effects has been labelled a “huge leap” forward. Trial results reflected favourably on the new technique, called vascular-targeted photodynamic therapy , in comparison to standard prostate cancer care.

New Ovarian Cancer Drug Wins Speedy FDA Approval

U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in a subset of hard-to-treat tumors. The Food and Drug Administration cleared the drug, Rubraca, from Clovis Oncology Inc. for women in advanced stages of the disease who have already tried at least two chemotherapy drugs.

Therapy Focus – Immunotherapy Closes In On Triple-Negative Tumors

Celgene admitted as much last week by saying it would not push a promising Abraxane-containing chemotherapy regimen into pivotal trials in this Several studies are already under way, most notably a large first-line phase III trial of Abraxane plus Roche’s anti-PD-L1 antibody Tecentriq. Early data are encouraging, and hopes are high that meaningful survival benefits will emerge in the next couple of years.